The proportions of patients with ArC, in the discovery and validation cohorts, who developed HCC increased with cumulative carriage of the risk increasing alleles rs738409:G in PNPLA3, rs58542926:T in TM6SF2 and rs2242652:G in TERT (online supplemental figure 11). Here, PNPLA3 is linked to hepatocellular carcinoma.